Gene Profiling

Variability Of Gene Expression Observed In Hepatocellular Carcinoma

Published in Gene Therapy Weekly, February 21st, 2002

by Sonia Nichols, senior medical writer - An Israeli study indicates that contrary to previous reports, there appears to be a great degree of differential gene expression in hepatocellular carcinoma, which may slow down the use of genetic "signatures" for diagnosing and treating patients with such cancers.

Authors of the new study work at the Hadassah University Hospital Goldyne Savad Institute of Gene Therapy in Israel, where they used the Atlas Human Cancer cDNA Expression Array, a test that can analyze the expression of 597 genes, to check for differential gene expression in three patients with hepatocellular carcinoma (HCC), a form of primary liver cancer. Recent...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2002-02-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry